Health data is an increasingly important resource for innovation and research, yet cross-Atlantic data collaborations are confounded by privacy legislation like GDPR, the EU AI Act, and regulations surrounding the European Health Data Space (EHDS). While privacy regulations are important safeguards for sensitive health data, these regulations can slow down or prevent data collaborations between the US and Europe that could significantly improve health.
VEIL.AI is excited to present our Next-Generation Anonymization technology at the upcoming BiotechX US conference in Philadelphia on September 17-18th. VEIL.AI’s solution goes beyond legacy anonymization methods, producing data that is high-quality and GDPR-compliant, facilitating seamless and compliant data exchanges between the US and Europe, an extension of our existing facilitation of cross-border data collaborations in Europe.
Next-Generation Anonymized data has proven privacy metrics and enables multiple use cases. Our technology can enable more efficient clinical trial planning through the sharing and re-use of clinical research data and re-use of existing legacy RCT data. The utility of VEIL.AI’s technology has already been shown in the Future Clinical Trials project with Bayer, where our partners found that VEIL.AI’s Next-Generation Anonymized Data could be used to draw the same conclusions as highly-regulated pseudonymized data.
Next-Generation Anonymization also enables efficient AI model training with high-quality data that mitigates data privacy risks (required by US NIST standards) and is EU AI Act, GDPR, and EHDS compliant. Moreover, VEIL.AI’s technology enables better access to Real World Evidence (RWE) for market access, risk sharing analysis, and health economics and outcome research (HEOR).
“We’re thrilled to be part of BiotechX US,” said Tuomo Pentikäinen, CEO of VEIL.AI. “Our technology is designed to solve the twin challenges of maximizing the value of health data while minimizing risks related to privacy and compliance. We believe VEIL.AI can play a significant role in shaping the future of precision medicine and look forward to discussing with other participants at the conference.”
BiotechX US is a top gathering for innovators in biotechnology, digital health, and AI. Attendees will have the opportunity to explore VEIL.AI’s unique solution firsthand and find out more about how our technology can be applied to solve your data privacy problems. For more information about VEIL.AI’s attendance at BiotechX US or to schedule a meeting with our team, contact [email protected].
